Hillstream BioPharma, Inc. is a biotech company that focuses on developing therapeutic candidates targeting iron-mediated cell death. Their product candidate, HSB-1216, induces this type of cell death, with applications in anti-cancer treatments. Additionally, they are working on developing other compounds such as HSB-888, HSB-510, and HSB-114 to treat different types of cancers.